Royalty Pharma plc
RPRX
Rangering i aksjer
#866
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Aksjekurs
$62.21
Sist synkronisert: 2026-10-20
Markedsverdi
$27.70B
Endring (1 dag)
3.22%
Endring (1 år)
65.98%
Land
US
Handel Royalty Pharma plc (RPRX)
Kategori
Healthcare
Historikk for aksjesplitt for Royalty Pharma plc (RPRX)
Aksjen Royalty Pharma plc (symbol: RPRX) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én RPRX-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 RPRX-aksjer.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én RPRX-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 RPRX-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 0 | - |
SE
|
|
| 0 | - |
FR
|
|
| 0 | - |
IT
|
|
| 0 | - |
US
|
|
| 7 | x40 |
HK
|
